SCHEMBL10028034

SCHEMBL10028034

CCOC(=O)C(C)(C(=O)OCC)C1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
FKBP1A P62942 2/20 0.38
CYP4F2 P78329 2/20 0.38
CYP4A11 Q02928 2/20 0.38
THRB P10828 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CHRM2 P08172 2/20 0.37
CHRM4 P08173 2/20 0.37
CHRM1 P11229 2/20 0.37
CHRM3 P20309 2/20 0.37
KMT2A Q03164 2/20 0.37
PKM P14618 2/20 0.36
PPM1B O75688 1/20 0.36
PTPN1 P18031 1/20 0.36
PPP1CC P36873 1/20 0.36
MMP8 P22894 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16732122 0.98 ALDH1A1 (0.41) ALDH1A1FKBP1ACYP4F2CYP4A11THRB
SCHEMBL10486329 0.96 CYP4F2 (0.38) ALDH1A1FKBP1ACYP4F2CYP4A11THRB
SCHEMBL9219742 0.92 CYP4F2 (0.40) ALDH1A1CYP4F2CYP4A11THRBKMT2A
SCHEMBL15973848 0.91 PKM (0.36) ALDH1A1FKBP1ACYP4F2CYP4A11THRB
SCHEMBL15973183 0.89 ALDH1A1 (0.38) ALDH1A1FKBP1ACYP4F2CYP4A11THRB
SCHEMBL28817661 0.87 CHRM2 (0.43) ALDH1A1CYP4F2CYP4A11ATMCHRM2
SCHEMBL16732048 0.85 CHRM2 (0.41) ALDH1A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL10708309 0.85 CYP4F2 (0.36) ALDH1A1CYP4F2CYP4A11THRBL3MBTL1
SCHEMBL8329844 0.84 THRB (0.40) ALDH1A1FKBP1ATHRBATML3MBTL1
SCHEMBL15910254 0.83 CYP4F2 (0.39) CYP4F2CYP4A11THRBKMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2876118-B1 METHOD FOR PRODUCING SOLID CATALYST COMPONENT FOR USE IN POLYMERIZATION OF OLEFIN, CATALYST FOR USE IN POLYMERIZATION OF OLEFIN, AND METHOD FOR PRODUCING OLEFIN POLYMER TOHO TITANIUM CO LTD (JP) 2022-04-06 EP disclosed
US-11028052-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-06-08 US disclosed
EP-3461816-B1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2021-03-24 EP disclosed
US-10421727-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2019-09-24 US disclosed
EP-3461816-A1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2019-04-03 EP disclosed
EP-2963065-B1 PRODUCTION METHOD FOR SOLID CATALYST COMPONENT FOR POLYMERIZING OLEFINS, CATALYST FOR POLYMERIZING OLEFINS, AND PRODUCTION METHOD FOR POLYMERIZED OLEFINS TOHO TITANIUM CO LTD (JP) 2018-04-04 EP disclosed
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2017-12-28 US disclosed
US-9840471-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2017-12-12 US disclosed
EP-2963063-B1 PRODUCTION METHOD FOR SOLID CATALYST COMPONENT FOR POLYMERIZING OLEFINS, CATALYST FOR POLYMERIZING OLEFINS, AND PRODUCTION METHOD FOR POLYMERIZED OLEFINS TOHO TITANIUM CO LTD (JP) 2017-06-14 EP disclosed
US-9670294-B2 Method for producing solid catalyst component for use in polymerization of olefin, catalyst for use in polymerization of olefin, and method for producing olefin polymer TOHO TITANIUM CO., LTD. (JP) 2017-06-06 US disclosed
US-20150166693-A1 METHOD FOR PRODUCING SOLID CATALYST COMPONENT FOR USE IN POLYMERIZATION OF OLEFIN, CATALYST FOR USE IN POLYMERIZATION OF OLEFIN, AND METHOD FOR PRODUCING OLEFIN POLYMER TOHO TITANIUM CO., LTD. (JP) 2015-06-18 US disclosed
EP-2876118-A1 METHOD FOR PRODUCING SOLID CATALYST COMPONENT FOR USE IN POLYMERIZATION OF OLEFIN, CATALYST FOR USE IN POLYMERIZATION OF OLEFIN, AND METHOD FOR PRODUCING OLEFIN POLYMER Toho Titanium CO., LTD. (JP) 2015-05-27 EP disclosed
WO-2014130582-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2014-08-28 WO disclosed
US-20130150234-A1 Catalyst Composition with Halo-Malonate Internal Electron Donor and Polymer From Same DOW GLOBAL TECHNOLOGIES LLC (US) 2013-06-13 US disclosed
US-20130150234-A1 Catalyst Composition with Halo-Malonate Internal Electron Donor and Polymer From Same DOW GLOBAL TECHNOLOGIES LLC (US) 2013-06-13 US disclosed
US-8383540-B2 Catalyst composition with halo-malonate internal electron donor and polymer from same DOW GLOBAL TECHNOLOGIES LLC (US) 2013-02-26 US disclosed
US-8383540-B2 Catalyst composition with halo-malonate internal electron donor and polymer from same DOW GLOBAL TECHNOLOGIES LLC (US) 2013-02-26 US disclosed
WO-2012087535-A1 CATALYST COMPOSITION WITH HALO-MALONATE INTERNAL ELECTRON DONOR AND POLYMER FROM SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2012-06-28 WO disclosed
US-20120157296-A1 Catalyst Composition with Halo-Malonate Internal Electron Donor and Polymer From Same W. R. GRACE & CO.-CONN. 2012-06-21 US disclosed
US-20120157296-A1 Catalyst Composition with Halo-Malonate Internal Electron Donor and Polymer From Same W. R. GRACE & CO.-CONN. 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421727-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885FKBP1A 727/4885CYP4F2 2227/4885
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885FKBP1A 727/4885CYP4F2 2227/4885
US-11028052-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885FKBP1A 727/4885CYP4F2 2227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.